June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Paolo Tarantino: Great recap of the randomized trials in the 2L+ HR+ MBC setting by Eva M Ciruelos
May 20, 2024, 15:03

Paolo Tarantino: Great recap of the randomized trials in the 2L+ HR+ MBC setting by Eva M Ciruelos

Paolo Tarantino shared on X/Twitter:

“Great recap of the randomized trials in the 2L+ HR+ MBC setting by Eva M Ciruelos.”

Source: Paolo Tarantino/X

Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a robust publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field. Dr. Tarantino’s dedication and innovative approach contribute significantly to the advancement of breast cancer treatment and researc.